INR 145.5
(1.35%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 91.5 Million INR | 0.0% |
2022 | - INR | 0.0% |
2021 | - INR | -100.0% |
2020 | 2.76 Million INR | 909.49% |
2019 | 274 Thousand INR | 0.0% |
2018 | - INR | -100.0% |
2017 | 21.46 Million INR | 0.0% |
2016 | - INR | 0.0% |
2015 | - INR | 0.0% |
2014 | - INR | -100.0% |
2013 | 215.66 Million INR | -14.05% |
2012 | 250.9 Million INR | -89.29% |
2011 | 2.34 Billion INR | 244.6% |
2010 | 679.95 Million INR | -83.35% |
2009 | 4.08 Billion INR | -14.11% |
2008 | 4.75 Billion INR | 12.27% |
2007 | 4.23 Billion INR | 26.27% |
2006 | 3.35 Billion INR | 86.59% |
2005 | 1.79 Billion INR | -11.58% |
2004 | 2.03 Billion INR | 1.5% |
2003 | 2 Billion INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | 0.0% |
2023 FY | 91.5 Million INR | 0.0% |
2023 Q2 | 50 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 91.5 Million INR | 0.0% |
2022 Q2 | - INR | 0.0% |
2022 Q4 | - INR | 0.0% |
2022 FY | - INR | 0.0% |
2022 Q1 | - INR | 0.0% |
2022 Q3 | - INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | - INR | -100.0% |
2021 Q2 | 300 Thousand INR | 0.0% |
2021 Q4 | - INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2020 Q2 | - INR | 0.0% |
2020 Q4 | 2.76 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 FY | 2.76 Million INR | 909.49% |
2020 Q3 | - INR | 0.0% |
2019 Q2 | - INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2019 Q3 | - INR | 0.0% |
2019 Q4 | 274 Thousand INR | 0.0% |
2019 FY | 274 Thousand INR | 0.0% |
2018 FY | - INR | -100.0% |
2018 Q4 | - INR | 0.0% |
2017 FY | 21.46 Million INR | 0.0% |
2017 Q4 | 21.46 Million INR | 0.0% |
2016 Q4 | - INR | 0.0% |
2016 FY | - INR | 0.0% |
2015 Q3 | - INR | 0.0% |
2015 FY | - INR | 0.0% |
2015 Q4 | - INR | 0.0% |
2015 Q2 | - INR | 0.0% |
2015 Q1 | - INR | 0.0% |
2014 Q3 | - INR | -100.0% |
2014 Q4 | - INR | 0.0% |
2014 FY | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 Q2 | 3.9 Million INR | 0.0% |
2013 Q2 | 385.2 Million INR | 0.0% |
2013 Q4 | 215.66 Million INR | 0.0% |
2013 FY | 215.66 Million INR | -14.05% |
2013 Q1 | - INR | -100.0% |
2013 Q3 | - INR | -100.0% |
2012 FY | 250.9 Million INR | -89.29% |
2012 Q2 | - INR | 0.0% |
2012 Q3 | - INR | 0.0% |
2012 Q4 | 250.9 Million INR | 0.0% |
2011 Q4 | 2.34 Billion INR | 0.0% |
2011 FY | 2.34 Billion INR | 244.6% |
2010 FY | 679.95 Million INR | -83.35% |
2009 FY | 4.08 Billion INR | -14.11% |
2008 Q4 | 4.75 Billion INR | 0.0% |
2008 FY | 4.75 Billion INR | 12.27% |
2007 FY | 4.23 Billion INR | 26.27% |
2006 FY | 3.35 Billion INR | 86.59% |
2005 FY | 1.79 Billion INR | -11.58% |
2004 FY | 2.03 Billion INR | 1.5% |
2003 FY | 2 Billion INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 93.604% |
Ind-Swift Limited | 10.13 Billion INR | 99.098% |
Bajaj HealthCare Limited | 3.32 Billion INR | 97.251% |
Sakar Healthcare Limited | 793.51 Million INR | 88.469% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.862% |
Innova Captab Limited | 2.45 Billion INR | 96.267% |
Divi's Laboratories Limited | 30 Million INR | -205.0% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -98.991% |
Morepen Laboratories Limited | 289.99 Million INR | 68.447% |
Mankind Pharma Limited | 2.07 Billion INR | 95.583% |
Sequent Scientific Limited | 4.87 Billion INR | 98.124% |
Wanbury Limited | 1.16 Billion INR | 92.145% |
Laurus Labs Limited | 25.77 Billion INR | 99.645% |
Nectar Lifesciences Limited | 6.35 Billion INR | 98.56% |
Glenmark Life Sciences Limited | 171.48 Million INR | 46.641% |
Hikal Limited | 8.17 Billion INR | 98.881% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 98.217% |
Neuland Laboratories Limited | 953.89 Million INR | 90.408% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 97.577% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.257% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 72.07% |
Themis Medicare Limited | 957.92 Million INR | 90.448% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 98.862% |
Lupin Limited | 29.21 Billion INR | 99.687% |
Amrutanjan Health Care Limited | 17.28 Million INR | -429.422% |
Wockhardt Limited | 23.56 Billion INR | 99.612% |
Vaishali Pharma Limited | 134.91 Million INR | 32.181% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 96.792% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -2.338% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.75% |
FDC Limited | 205.18 Million INR | 55.406% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.543% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 71.087% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.671% |
Venus Remedies Limited | 413.3 Million INR | 77.861% |
ZIM Laboratories Limited | 1.08 Billion INR | 91.592% |
Bliss GVS Pharma Limited | 998.4 Million INR | 90.835% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | -364.467% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.024% |
Albert David Limited | 33.24 Million INR | -175.254% |
Ajanta Pharma Limited | 352.8 Million INR | 74.065% |
Hester Biosciences Limited | 2.44 Billion INR | 96.256% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 85.922% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.095% |
Gufic Biosciences Limited | 3.32 Billion INR | 97.252% |
Windlas Biotech Limited | 36.41 Million INR | -151.305% |
Procter & Gamble Health Limited | 95.6 Million INR | 4.289% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 70.816% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 90.71% |
Granules India Limited | 13.15 Billion INR | 99.304% |
Aarti Drugs Limited | 5.64 Billion INR | 98.378% |
Bal Pharma Limited | 1.39 Billion INR | 93.448% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.355% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.72% |
Lincoln Pharmaceuticals Limited | 10.66 Million INR | -757.705% |
Medicamen Biotech Limited | 308.17 Million INR | 70.309% |
Unichem Laboratories Limited | 2.47 Billion INR | 96.303% |
Bafna Pharmaceuticals Limited | 243.89 Million INR | 62.484% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1984.757% |
Valiant Laboratories Limited | 767.08 Million INR | 88.072% |
Orchid Pharma Limited | 1.35 Billion INR | 93.231% |
Medico Remedies Limited | 80.5 Million INR | -13.659% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 44.951% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.364% |
Brooks Laboratories Limited | 56.41 Million INR | -62.179% |
Syncom Formulations (India) Limited | 724.86 Million INR | 87.377% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.983% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.773% |
NATCO Pharma Limited | 3.71 Billion INR | 97.535% |
Suven Life Sciences Limited | 7.09 Million INR | -1189.277% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 95.27% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.636% |
Indoco Remedies Limited | 6.71 Billion INR | 98.638% |
Alpa Laboratories Limited | 52.46 Million INR | -74.402% |
Lasa Supergenerics Limited | 220.76 Million INR | 58.553% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 85.037% |